Corporate Presentation March 2021 Forward-Looking Statements This presentation contains statements about our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks relating to: both our and our collaborators' ability to successfull ...

Corporate Presentation March 2021 Forward-Looking Statements This presentation contains statements about our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks relating to: both our and our collaborators' ability to successfull ...

/IKING T H E R A P E U T I C S Corporate Presentation February 2021 Forward-Looking Statements This presentation contains statements about our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks relating to: both our and our col ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2020 Earnings Conference Call February 17, 2021 4:30 PM ET Company Participants Stephanie Diaz – Manager-Investor Relations Brian Lian – President and Chief Executive Officer Greg Zante – Chief Financial Officer Conference Call Participants Derek Archila – Stifel Joon Lee – Truist Securities Michael Morabito – Chardan Capital Markets Matt Luchini – BMO Capital Steve Seedhouse – Raymond James Julian Harrison – BTIG Andy Hsieh – William Blair Yale Jen – Laidlaw & Co. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37355 Viking Therapeutics, Inc. (Exact name of Registrant as specified in its Charter) Delaware 46-1073877 ( State or other jurisdict ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2020 Earnings Conference Call October 28, 2020 4:30 PM ET Company Participants Stephanie Diaz - Investor Relations, Brian Lian - President and Chief Executive Officer Greg Zante - Senior Vice President, Finance Conference Call Participants Joon Lee - Truist Securities Derek Archila - Stifel Ryan Deschner - Raymond James Mathew Luchini - BMO Michael Morabito - Chardan Capital Markets David Bautz - Zacks Yale Jen - Laidlaw & Company Jay Olson - Oppenheimer Andy Hsie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37355 VIKING THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 46-1073877 (State or other j ...

IKING HERAPE NOVEL TI FOR METABO ENDOCRINE DISORDER Corporate Presentation August 2020 Forward-Looking Statements 2 This presentation contains statements about our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks relating to: ...

IKING E R A P E U T I C S NOVEL TI FOR METABO ENDOCRINE DISORDER Corporate Presentation July 2020 Forward-Looking Statements 2 This presentation contains statements about our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks r ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2020 Results Earnings Conference Call July 29, 2020 4:30 PM ET Company Participants Stephanie Diaz - Manager, Investor Relations Brian Lian - President and CEO Greg Zante - Senior Vice President, Finance Conference Call Participants Joon Lee - SunTrust Michael Morabito - Chardan Capital Markets Matt Luchini - BMO Capital Steve Seedhouse - Raymond James Jay Olson - Oppenheimer Yale Jen - Laidlaw & Company Scott Henry - ROTH Capital Andy Hsieh - William Blair Julian ...